17 November 2014 – The Australian Self Medication Industry (ASMI) is celebrating its 40th anniversary this year at the ASMI 2014 Annual Conference and a gala dinner tomorrow.
ASMI Executive Director Dr Deon Schoombie said: “Over the last 40 years ASMI has become the voice of Australia’s non-prescription medicines industry, significantly influencing medicines policy and regulation.
“Whether embracing self and co-regulation, championing QUM or placing self care on the national agenda, ASMI has always taken a broader view in order to become an organisation aligned with the National Medicines Policy.
“Over the past four decades ASMI has made a meaningful difference to the industry, locally and internationally, and more importantly, to the lives of Australians.
“As ASMI looks ahead to the future with excitement and a sense of expectation.
“There is a mood for change in Canberra driven by the Federal Government’s de-regulation agenda, the unsustainable health budget and the search for cost savings. To capture this moment in time we will pursue a regulatory reform agenda and work with other organisations and industry bodies to develop the Self Care Alliance into an independent multi-stakeholder think tank,” Dr Schoombie added.
ASMI’s achievements during its first 40 years are many and are celebrated in a book written by former ASMI Executive Director, Juliet Seifert: ‘Milestones. How ASMI became the voice of Australia’s self-medication industry.’ This can be downloaded from the website here.
Some of ASMI’s key accomplishments during the last 40 years as outlined in the book are:
– Participation in the development of the National Medicines Policy
– Introduction of tamper evident packaging
– Development of Crisis Management Guidelines
– Introduction of performance-based labelling
– Placing self care on the national agenda
– Partnering with Macquarie University to build the evidence base around self care and non-prescription products
– Partnered with NPS Medicinewise to develop guidelines to promote quality use of medicines in supermarkets
– S3 advertising allowed for ingredients listed in Appendix H of the Standard for Uniform Scheduling of Drugs and Poisons
– Successfully negotiated GST exempt status for S2 and other unscheduled products
– Inclusion of complementary healthcare products into the National Medicines Policy
– Partnering with Life Education to educate kids about QUM
– Led the rapid industry response to the Pan Pharmaceuticals recall crisis.
|For more information or to arrange a media interview, please contact: Marie Kelly-Davies PR Manager, Australian Self Medication Industry (ASMI) M:0408 256 381 E: email@example.com|